A U.S. study found that colon cancer patients who regularly take aspirin have a lower risk of disease recurrence, are less likely to die from colon cancer and are less likely to die from any cause. "These results suggest that aspirin may influence the biology of established colorectal tumors in addition to preventing their occurrence," one researcher said.

Full Story:

Related Summaries